Utah Medical Products, Inc. (UTMD)
74.23
-0.83
(-1.11%)
USD |
NASDAQ |
Oct 23, 16:00
74.24
+0.01
(+0.01%)
After-Hours: 20:00
Utah Medical Products Profit Margin (Quarterly) : 32.33% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 32.33% |
| June 30, 2026 | 31.49% |
| March 31, 2026 | 29.86% |
| December 31, 2025 | 28.37% |
| September 30, 2025 | 26.81% |
| June 30, 2025 | 30.62% |
| March 31, 2025 | 31.32% |
| December 31, 2024 | 31.69% |
| September 30, 2024 | 35.61% |
| June 30, 2024 | 33.20% |
| March 31, 2024 | 34.89% |
| December 31, 2023 | 34.75% |
| September 30, 2023 | 31.47% |
| June 30, 2023 | 32.64% |
| March 31, 2023 | 33.66% |
| December 31, 2022 | 33.56% |
| September 30, 2022 | 33.04% |
| June 30, 2022 | 30.56% |
| March 31, 2022 | 28.68% |
| December 31, 2021 | 32.00% |
| September 30, 2021 | 33.46% |
| June 30, 2021 | 27.18% |
| March 31, 2021 | 27.58% |
| December 31, 2020 | 28.41% |
| September 30, 2020 | 27.99% |
| Date | Value |
|---|---|
| June 30, 2020 | 14.94% |
| March 31, 2020 | 28.80% |
| December 31, 2019 | 36.84% |
| September 30, 2019 | 29.65% |
| June 30, 2019 | 29.76% |
| March 31, 2019 | 29.25% |
| December 31, 2018 | 34.78% |
| September 30, 2018 | 65.08% |
| June 30, 2018 | 39.29% |
| March 31, 2018 | 37.59% |
| December 31, 2017 | -24.72% |
| September 30, 2017 | 35.77% |
| June 30, 2017 | 35.74% |
| March 31, 2017 | 34.47% |
| December 31, 2016 | 30.69% |
| September 30, 2016 | 30.40% |
| June 30, 2016 | 31.07% |
| March 31, 2016 | 31.23% |
| December 31, 2015 | 33.50% |
| September 30, 2015 | 30.64% |
| June 30, 2015 | 28.07% |
| March 31, 2015 | 26.06% |
| December 31, 2014 | 29.29% |
| September 30, 2014 | 26.33% |
| June 30, 2014 | 27.01% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 7.07% |
| AngioDynamics, Inc. | -8.77% |
| Alphatec Holdings, Inc. | -12.07% |
| AtriCure, Inc. | 5.83% |
| Baxter International, Inc. | 4.56% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.82% |
| Return on Assets | 8.56% |
| Return on Invested Capital | 8.81% |
| Gross Profit Margin (Quarterly) | 55.71% |
| Operating Margin (Quarterly) | 32.42% |
| Return on Net Operating Assets | 28.11% |